HealthEquity stock’s recent year-to-date underperformance is partly due to its disclosure of fraud against some of its HSA customers and near-term investor concerns about recent management changes.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=37760 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for ...

Raymond James upgraded HealthEquity (HQY) to Strong Buy from Outperform with a price target of $115, down from $120. The firm upgrade the ...

HQY stock is down more than 13% YTD amid cyber threats and rising costs, but strong HSA fundamentals remain. Is it time to hold or fold? Let's break it down.

Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Mizuho started ...

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (NasdaqGS ... VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,744K shares ...

These fell short of expectations on several metrics. HealthEquity divulged its fourth-quarter and full-year fiscal 2024 results just after market close on Tuesday. These showed that the company ...

Seeking Alpha Investing Group Leader Quad 7 Capital attributed the selloff to a mixed earnings report and the stock’s premium valuation. While HealthEquity's (NASDAQ:HQY) Q4 revenue jumped ~19% ...

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (BMV ... VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,744K shares ...